Sarepta Therapeutics, Inc. (SRPT)
16.87
+0.21
(+1.26%)
USD |
NASDAQ |
Mar 17, 16:00
16.89
+0.02
(+0.12%)
After-Hours: 19:22
Sarepta Therapeutics Market Cap : 1.771B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 286.50B |
| REGENXBIO, Inc. | 446.97M |
| Keros Therapeutics, Inc. | 223.20M |
| Gilead Sciences, Inc. | 179.27B |
| Alnylam Pharmaceuticals, Inc. | 42.50B |
Market Cap Related Metrics
| PS Ratio | 0.7848 |
| Price to Book Value | 1.553 |
| Price | 16.87 |
| Earnings Yield | -50.02% |